Ripple kopen? Dit zijn de mogelijkheden

Ipsen Aandeel

113,10EUR -0,40EUR -0,35%

Taxaties voor Ipsen

2018 2019e 2020e 2021e 2022e
Dividend 1,00 1,14 1,27 1,37 1,53
Dividendrendement (in %) 0,92 1,01 1,12 1,22 1,35
K/W-verhouding 18,43 16,42 14,44 12,88 12,45
Winst/Aandeel 5,91 6,86 7,80 8,75 9,05

Nieuws voor Ipsen

Geen nieuws beschikbaar
Meer nieuws

Analisten over Ipsen

meer analisten

Ipsen Peer Group

Ipsen 113,10

Invoer toevoegen

Wat denkt u?

Profiel Ipsennaar bedrijfsprofiel

Ipsen SA manufactures pharmaceutical products for oncology, neuroscience and rare diseases. It operates through following segments: Specialty Care and Consumer Healthcare. The Specialty Care segment focuses on Oncology with Somatuline, a somatostatin analog for the treatment of neuroendocrine tumors; Cabometyx, the single-agent treatment with significant improvement across all key efficacy endpoints in second-line renal cell carcinoma; Onivyde, a differentiated product with overall survival benefit addressing a high unmet medical need in pancreatic cancer; and Decapeptyl, an established and growing product in Europe and China for prostate cancer and Rare Diseases with Nutropin, a liquid formulation of recombinant human growth hormone and Increlex, a recombinant insulin-like growth factor of human origin. The Consumer Healthcare segment include brands such as Smecta, a naturally extracted purified clay for the symptomatic treatment of acute diarrhea; Tanakan, a standardized extract from the leaves of Ginkgo biloba for the treatment of various neurological and neuro-sens or ial disorders; Forlax, an osmotic laxative indicated for the symptomatic treatment of constipation in adults and children; and Fortrans, a colon cleansing solution indicated for patients in preparation for endoscopic, radiological examinations or colonic surgery. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.

Aandelenkoers Ipsen in EURPush activeren

Koers 113,10 EUR -0,40 -0,35 %
Tijd 17:35:15
Handelsdatum 19.07.2019
Opening 114,00
Slot 113,50
Hoogste 115,60
Laagste 112,60
52 W. Hoog 155,95
52 W. Laag 98,85
52 W. Perf.
Volume (Aantal) 119.284
Marktkap. (EUR) 9,45 Mrd

Naar aandeel Ipsen

ISIN FR0010259150
Indices CAC MID 60, SBF 120

Ipsen Kerncijfers

Marktkapitalisatie in Euro 9,45 Mrd
Vrij verhandelbaar in %
Aantal Aandelen 83,81
Kasstroom/Aandeel in lokale valuta 6,84
Boekwaarde/Aandeel in lokale valuta 22,13
60 Dagen Volatiliteit 37,24
K/B verhouding

Ipsen Historische koersen

19-7-2019 113,10 119.284
18-7-2019 113,50 121.105
17-7-2019 111,00 182.984
16-7-2019 114,50 147.886
15-7-2019 113,90 162.553